Literature DB >> 20537715

Basal cortisol levels in relation to dimensions and DSM-IV categories of depression and anxiety.

Gerthe Veen1, Irene M van Vliet, Roel H DeRijk, Erik J Giltay, Johannes van Pelt, Frans G Zitman.   

Abstract

The Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV classification may fail to adequately distinguish neuroendocrine factors involved in the etiology of depressive and anxiety disorders. Continuous phenotypic dimensions may correlate better with underlying neuroendocrine dysregulations. We compared the categorical DSM-IV diagnoses with a dimensional approach in the same group of outpatients with depressive (n=36), anxiety (n=18), and comorbid depressive and anxiety (n=19) disorders, who were free of psychotropic medication, and in 36 healthy controls. The Mood and Anxiety Symptom Questionnaire (MASQ) was used to measure the three dimensions of the tripartite model, i.e., anhedonic depression, anxious arousal, and general distress. The salivary cortisol awakening response (CAR) (0, 30, 45, and 60 min after awakening), and diurnal cortisol decline (11:00 h, 15:00 h, 19:00 h, and 23:00 h) were analyzed for linear and nonlinear associations. The CAR showed statistically significant nonlinear relationships with two MASQ dimensions, i.e., anhedonic depression and general distress, but no differences between DSM-IV categories. The diurnal cortisol decline was linearly related to the MASQ dimensions anhedonic depression and general distress and significantly higher AUC(diurnal) levels and a steeper slope were found in depressive patients compared to controls using DSM-IV categories. The present study shows that linear and nonlinear associations with salivary cortisol are detected when using phenotypic dimensions and may be complementary to phenotypic DSM-IV categories when doing neuroendocrine research.
Copyright © 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20537715     DOI: 10.1016/j.psychres.2009.07.013

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

1.  Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling.

Authors:  Casey E O'Neill; Ryan J Newsom; Jacob Stafford; Talia Scott; Solana Archuleta; Sophia C Levis; Robert L Spencer; Serge Campeau; Ryan K Bachtell
Journal:  Psychoneuroendocrinology       Date:  2016-02-01       Impact factor: 4.905

2.  Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.

Authors:  Eric J Lenze; Tamara Hershey; John W Newcomer; Jordan F Karp; Daniel Blumberger; Jennifer Anger; Peter Doré; David Dixon
Journal:  Int J Geriatr Psychiatry       Date:  2014-03-14       Impact factor: 3.485

3.  Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.

Authors:  R Uher; R H Perlis; N Henigsberg; A Zobel; M Rietschel; O Mors; J Hauser; M Z Dernovsek; D Souery; M Bajs; W Maier; K J Aitchison; A Farmer; P McGuffin
Journal:  Psychol Med       Date:  2011-09-20       Impact factor: 7.723

Review 4.  Psychosocial functioning and the cortisol awakening response: Meta-analysis, P-curve analysis, and evaluation of the evidential value in existing studies.

Authors:  Ian A Boggero; Camelia E Hostinar; Eric A Haak; Michael L M Murphy; Suzanne C Segerstrom
Journal:  Biol Psychol       Date:  2017-09-14       Impact factor: 3.251

Review 5.  Investigating the nature of co-occurring depression and anxiety: Comparing diagnostic and dimensional research approaches.

Authors:  Katharina Kircanski; Joelle LeMoult; Sarah Ordaz; Ian H Gotlib
Journal:  J Affect Disord       Date:  2016-08-13       Impact factor: 4.839

6.  HPA-axis and inflammatory reactivity to acute stress is related with basal HPA-axis activity.

Authors:  Xuejie Chen; Danielle Gianferante; Luke Hanlin; Alexander Fiksdal; Juliana G Breines; Myriam V Thoma; Nicolas Rohleder
Journal:  Psychoneuroendocrinology       Date:  2017-02-06       Impact factor: 4.905

Review 7.  Diurnal cortisol slopes and mental and physical health outcomes: A systematic review and meta-analysis.

Authors:  Emma K Adam; Meghan E Quinn; Royette Tavernier; Mollie T McQuillan; Katie A Dahlke; Kirsten E Gilbert
Journal:  Psychoneuroendocrinology       Date:  2017-05-24       Impact factor: 4.905

8.  Persistent heightened cortisol awakening response and adolescent internalizing symptoms: a 3-year longitudinal community study.

Authors:  Stefanie A Nelemans; William W Hale; Susan J T Branje; Pol A C van Lier; Lucres M C Jansen; Evelien Platje; Tom Frijns; Hans M Koot; Wim H J Meeus
Journal:  J Abnorm Child Psychol       Date:  2014

Review 9.  Vasopressin V1B Receptor Antagonists as Potential Antidepressants.

Authors:  Shigeyuki Chaki
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-14       Impact factor: 5.176

10.  Cardiac vagal control and theoretical models of co-occurring depression and anxiety: a cross-sectional psychophysiological study of community elderly.

Authors:  Hsi-Chung Chen; Cheryl C H Yang; Terry B J Kuo; Tung-Ping Su; Pesus Chou
Journal:  BMC Psychiatry       Date:  2012-07-30       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.